11月17日，吉林敖东盘中下跌2.01%，截至09:48，报20.49元/股，成交1.01亿元，换手率0.41%，总市值 245.04亿元。 吉林敖东所属申万行业为：医药生物-中药Ⅱ-中药Ⅲ。所属概念板块包括：券商相关、低市盈率、零售 药店、融资融券、维生素等。 截至9月30日，吉林敖东股东户数6.12万，较上期减少7.18%；人均流通股19456股，较上期增加7.73%。 2025年1月-9月，吉林敖东实现营业收入16.40亿元，同比减少14.10%；归母净利润22.60亿元，同比增长 81.70%。 分红方面，吉林敖东A股上市后累计派现46.64亿元。近三年，累计派现18.81亿元。 机构持仓方面，截止2025年9月30日，吉林敖东十大流通股东中，南方中证500ETF（510500）位居第四 大流通股东，持股1393.00万股，相比上期减少31.79万股。香港中央结算有限公司位居第五大流通股 东，持股1181.75万股，相比上期减少319.62万股。汇添富中证中药ETF（560080）位居第九大流通股 东，持股597.74万股，相比上期增加156.82万股。 责任编辑：小浪快报 资金流向方面，主力资金净流 ...

Core Viewpoint - Jilin Aodong's stock price has shown a significant increase this year, with a notable rise in net profit despite a decrease in revenue, indicating potential resilience in its business model and market positioning [1][2]. Financial Performance - As of September 30, 2025, Jilin Aodong reported a revenue of 1.64 billion yuan, a year-on-year decrease of 14.10%, while the net profit attributable to shareholders was 2.26 billion yuan, reflecting a year-on-year increase of 81.70% [2]. - The company's stock price increased by 28.67% year-to-date, with a 0.84% rise over the last five trading days, 6.18% over the last 20 days, and 13.91% over the last 60 days [1]. Shareholder Information - The number of shareholders decreased by 7.18% to 61,200, while the average circulating shares per person increased by 7.73% to 19,456 shares [2]. - The company has distributed a total of 4.664 billion yuan in dividends since its A-share listing, with 1.881 billion yuan distributed in the last three years [3]. Ownership Structure - As of September 30, 2025, the top ten circulating shareholders included Southern CSI 500 ETF, holding 13.93 million shares (a decrease of 317,900 shares), and Hong Kong Central Clearing Limited, holding 11.82 million shares (a decrease of 319,620 shares) [3].

Core Viewpoint - Jilin Aodong's stock price has shown significant growth this year, with a 23.47% increase, and the company is actively involved in various sectors including traditional Chinese medicine and health products [1][2]. Financial Performance - For the first half of 2025, Jilin Aodong reported a revenue of 1.126 billion yuan, a year-on-year decrease of 20.21%, while the net profit attributable to shareholders was 1.282 billion yuan, reflecting a year-on-year increase of 138.44% [2]. - Cumulative cash dividends since the company's A-share listing amount to 4.664 billion yuan, with 1.881 billion yuan distributed over the past three years [3]. Shareholder Information - As of June 30, 2025, the number of shareholders for Jilin Aodong was 66,000, a decrease of 1.60% from the previous period, with an average of 18,059 circulating shares per shareholder, an increase of 1.62% [2]. - The top ten circulating shareholders include Hong Kong Central Clearing Limited, which increased its holdings by 4.6149 million shares to 15.0138 million shares, and Southern CSI 500 ETF, which increased its holdings by 1.9148 million shares to 14.2479 million shares [3].

Core Viewpoint - Jilin Aodong's stock price has shown significant growth this year, with a 20.41% increase, and the company is actively involved in various sectors including traditional Chinese medicine and health products [1][2]. Financial Performance - For the first half of 2025, Jilin Aodong reported a revenue of 1.126 billion yuan, a year-on-year decrease of 20.21%, while the net profit attributable to shareholders was 1.282 billion yuan, reflecting a year-on-year increase of 138.44% [2]. - Cumulative cash dividends since the company's A-share listing amount to 4.43 billion yuan, with 1.647 billion yuan distributed over the past three years [3]. Stock Market Activity - As of October 9, Jilin Aodong's stock price was 20.44 yuan per share, with a market capitalization of 24.444 billion yuan. The stock has seen a trading volume of 292 million yuan and a turnover rate of 1.23% [1]. - The stock has experienced a net inflow of 8.2328 million yuan from main funds, with significant buying and selling activity noted [1]. Shareholder Structure - As of June 30, 2025, the number of shareholders decreased to 66,000, with an average of 18,059 circulating shares per person, an increase of 1.62% [2]. - The top ten circulating shareholders include Hong Kong Central Clearing Limited and Southern CSI 500 ETF, with notable increases in their holdings [3].

9月29日，吉林敖东涨5.23%，截至发稿，报20.12元/股，成交4.19亿元，换手率1.80%，总市值240.61亿 元。 资料显示，吉林敖东药业集团股份有限公司位于吉林省敦化市敖东大街2158号，成立日期1993年3月20 日，上市日期1996年10月28日，公司主营业务涉及中成药、生物化学药研发、制造和销售,同时积极布 局保健食品、食品、养殖、种植等领域。主营业务收入构成为：中药60.90%，连锁药店批发和零售 16.59%，化学药品12.73%，食品7.39%，其他产品1.76%，其他(补充)0.62%。 从基金十大重仓股角度 数据显示，南方基金旗下1只基金重仓吉林敖东。南方中证500增强策略ETF（560100）二季度持有股数 2.98万股，占基金净值比例为0.63%，位居第九大重仓股。根据测算，今日浮盈赚取约2.98万元。 南方中证500增强策略ETF（560100）成立日期2022年1月26日，最新规模8041.32万。今年以来收益 27.63%，同类排名1852/4221；近一年收益45.75%，同类排名1710/3836；成立以来收益21.77%。 南方中证500增强策略ETF（56010 ...

Core Viewpoint - Jilin Aodong's stock performance shows a mixed trend with a year-to-date increase of 13.98% and a recent decline over the past 20 days, indicating potential volatility in the market [1][2]. Group 1: Stock Performance - As of September 11, Jilin Aodong's stock price increased by 2.00% to 19.35 CNY per share, with a trading volume of 1.94 billion CNY and a turnover rate of 0.85%, resulting in a total market capitalization of 231.41 billion CNY [1]. - The stock has seen a year-to-date increase of 13.98%, a 2.60% rise over the last five trading days, a 1.38% decline over the last 20 days, and a 21.35% increase over the last 60 days [1]. Group 2: Financial Performance - For the first half of 2025, Jilin Aodong reported a revenue of 1.126 billion CNY, a year-on-year decrease of 20.21%, while the net profit attributable to shareholders was 1.282 billion CNY, reflecting a significant year-on-year increase of 138.44% [2]. Group 3: Shareholder and Dividend Information - Since its A-share listing, Jilin Aodong has distributed a total of 4.43 billion CNY in dividends, with 1.647 billion CNY distributed over the past three years [3]. - As of June 30, 2025, the number of shareholders decreased to 66,000, while the average circulating shares per person increased by 1.62% to 18,059 shares [2][3]. - Among the top ten circulating shareholders, Hong Kong Central Clearing Limited holds 15.0138 million shares, an increase of 4.6149 million shares from the previous period [3].

Group 1 - The latest stock price of Jilin Aodong is 20.55 yuan, an increase of 0.61 yuan from the previous trading day, with a trading volume of 6.22 billion yuan [1] - Jilin Aodong is primarily engaged in the research, development, manufacturing, and sales of traditional Chinese medicine and biochemical drugs, covering various therapeutic areas including cardiovascular, digestive system, and anti-tumor treatments [1] - On August 22, Jilin Aodong announced that it has returned all 300 million yuan of temporarily idle raised funds to the special account for raised funds [1] Group 2 - On the same day, the net inflow of main funds into Jilin Aodong was 33.96 million yuan, while the net outflow over the past five days was 71.64 million yuan [2]